Nintedanib Impurity 73 | CAS 652140-28-8 - Request Quote
Nintedanib Impurity 73
| SZ CAT No: | SZ-N023103 |
| CAS No | 652140-28-8 |
| Mol.F. | C14H22N4O |
| Mol.Wt. | 262.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 73 is chemically N-(3-Aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide. Nintedanib Impurity 73 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 73 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 652140-28-8
Purchase 652140-28-8
Order 652140-28-8
Enquire 652140-28-8
price of 652140-28-8
652140-28-8 Supplier
652140-28-8 Manufacturer
652140-28-8 Exporter
buy high quality Nintedanib Impurity 73
Purchase Nintedanib Impurity 73
Nintedanib Impurity 73 suppliers
Nintedanib Impurity 73 manufacturers
Nintedanib Impurity 73 price
Order Nintedanib Impurity 73
Enquire Nintedanib Impurity 73
Nintedanib Impurity 73 cost
Nintedanib Impurity 73 Supplier
Nintedanib Impurity 73 Distributor
Nintedanib Impurity 73 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 73 for ANDA Filing
Nintedanib Impurity 73 for Forced Degradation Studies
Nintedanib Impurity 73 Identification Standards
Nintedanib Impurity 73 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


